For the readers interested in the stock health of Timber Pharmaceuticals Inc. (TMBR). It is currently valued at $1.06. When the transactions were called off in the previous session, Stock hit the highs of $1.18, after setting-off with the price of $1.10. Company’s stock value dipped to $1.01 during the trading on the day. When the trading was stopped its value was $1.09.
Recently in News on September 15, 2020, Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04. – Formal notice confirms intent to grant patent for pharmaceutical tetracycline compositions for dermatological use -. You can read further details here
Timber Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.6000 on 01/27/20, with the lowest value was $0.8701 for the same time period, recorded on 09/24/20.
Timber Pharmaceuticals Inc. (TMBR) full year performance was -73.72%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Timber Pharmaceuticals Inc. shares are logging -91.59% during the 52-week period from high price, and 21.83% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.87 and $12.60.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1552302 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Timber Pharmaceuticals Inc. (TMBR) recorded performance in the market was -79.17%, having the revenues showcasing -51.82% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 13.10M, as it employees total of 3 workers.
Market experts do have their say about Timber Pharmaceuticals Inc. (TMBR)
During the last month, 0 analysts gave the Timber Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.8534, with a change in the price was noted -3.0500. In a similar fashion, Timber Pharmaceuticals Inc. posted a movement of -74.21% for the period of last 100 days, recording 835,681 in trading volumes.
Technical breakdown of Timber Pharmaceuticals Inc. (TMBR)
Raw Stochastic average of Timber Pharmaceuticals Inc. in the period of last 50 days is set at 13.28%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 61.28%. In the last 20 days, the company’s Stochastic %K was 65.33% and its Stochastic %D was recorded 50.36%.
Bearing in mind the latest performance of Timber Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -79.17%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -69.33%, alongside a downfall of -73.72% for the period of the last 12 months. The shares increased approximately by 4.95% in the 7-day charts and went up by 1.92% in the period of the last 30 days. Common stock shares were lifted by -51.82% during last recorded quarter.